<DOC>
	<DOCNO>NCT00000703</DOCNO>
	<brief_summary>To determine safety effectiveness combination chemotherapy-radiation-zidovudine ( AZT ) treatment patient peripheral lymphoma . Other chemotherapy try patient AIDS relate lymphoma , result satisfactory . This study show whether combination chemotherapy , radiation , AZT effective less toxic previously use treatment .</brief_summary>
	<brief_title>Chemotherapy Azidothymidine , With Without Radiotherapy , High Grade Lymphoma AIDS-Risk Group Members</brief_title>
	<detailed_description>Other chemotherapy try patient AIDS relate lymphoma , result satisfactory . This study show whether combination chemotherapy , radiation , AZT effective less toxic previously use treatment . All patient receive combination chemotherapy AZT . The combination chemotherapy repeat every 3 4 week maximum total 6 cycle . Each cycle consist doxorubicin , bleomycin , cyclophosphamide , vincristine day 1 , dexamethasone day 1-5 , methotrexate day 15 . Patients meningeal bone marrow disease receive radiation intrathecal cytarabine ( ARA-C ) without receive ARA-C without radiation . Patients document lymphomas central nervous system initial workup start radiation soon possible intrathecal ARA-C ( t.i.w . cerebrospinal fluid clear every month 1 year ) ; patient normal lumbar puncture , brain scan , bone marrow first diagnosis begin radiation day 1 cycle 3 chemotherapy . Lumbar puncture evaluation do four time first cycle , day 1 , 8 , 21 , 28 . AZT administer every 4 hour , 7 day week , begin completion combine chemotherapy , patient achieve complete remission lymphoma , continue 1 year .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<mesh_term>Bleomycin</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Allopurinol</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Ibuprofen . Standard antiemetic agent . Ganciclovir therapy sight lifethreatening Cytomegalovirus infection . Zidovudine methotrexate may resume ganciclovir maintenance phase . Exclusion Criteria Coexisting Condition : The following patient exclude study : Patients recurrent infection may interfere plan protocol . Patients second active tumor nonmelanomatous skin cancer Kaposi 's sarcoma . Patients stage IE primary central nervous system lymphoma . Concurrent Medication : Excluded : Corticosteroids . Aspirin . Acetaminophen . Nonsteroidal antiinflammatory drug , except ibuprofen . Chemotherapy infection associate neutropenia . Zidovudine ( AZT ) infection associate neutropenia . Investigational therapy , except ganciclovir therapy sight lifethreatening cytomegalovirus infection . AZT methotrexate suspend induction therapy ganciclovir . The following patient exclude study : Patients recurrent infection may interfere plan protocol . Patients second active tumor nonmelanomatous skin cancer Kaposi 's sarcoma . Patients stage IE primary central nervous system lymphoma . Prior Medication : Excluded : Zidovudine ( AZT ) . Excluded within 2 week study entry : Immunomodulating agent . Antiretroviral therapy prior diagnosis lymphoma . Patients must demonstrate follow clinical laboratory finding : Any stage disease , include stage I . Newly diagnose , previously untreated highgrade lymphoma . Presence measurable tumor parameter ( ) . Adequate hepatic , renal , bone marrow function .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Vincristine</keyword>
	<keyword>Lymphoma</keyword>
	<keyword>Methotrexate</keyword>
	<keyword>Cyclophosphamide</keyword>
	<keyword>Cytarabine</keyword>
	<keyword>Dexamethasone</keyword>
	<keyword>Doxorubicin</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Combined Modality Therapy</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Antineoplastic Agents , Combined</keyword>
	<keyword>Zidovudine</keyword>
	<keyword>Bleomycin</keyword>
</DOC>